Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial

Overview of attention for article published in BMC Infectious Diseases, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 19 X posts from 14 X users, with an upper bound of 5,478 followers.

@VoltageBad @SpcialTK1 @decoder_l @amine_umlil L'hydroxychloroquine ne soigne pas le Covid, ni en préventif ni en curatif, et au contraire augmente la mortalité du Covid https://t.co/kEooa57p4Q https://t.co/8eNE1L8RlY https://t.co/lyp4GcS69t https://t.

@Cristi_Neagu @Ellis_X5 @kylenabecker There's no blanket ban, all of those options were considered. There simply isn't enough evidence to justify their use. https://t.co/n37PaR6eW1 https://t.co/guO2ELbHrQ https://t.co/RagGIIJEeJ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.